当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3719673
自主品牌
已选条件
-
T6198Dolutegravir度鲁特韦；多替拉韦；GSK1349572；S/GSK1349572
Dolutegravir (IC50=2.7 nM), a two-metal-binding HIV integrase inhibitor, exhibits medium activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
价 格：￥电议型 号：T6198产 地：中国大陆
-
T11074Dolutegravir intermediate-11-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyr
Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.
价 格：￥电议型 号：T11074产 地：中国大陆
-
T11074Dolutegravir intermediate-1Dolutegravir intermediate-1
Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.
价 格：￥电议型 号：T11074产 地：美洲
-
T2329Dolutegravir sodiumDolutegravir sodium,GSK-1349572A,GSK1349572
Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
价 格：￥电议型 号：T2329产 地：美洲
-
T6198DolutegravirDolutegravir,GSK1349572,S/GSK1349572
Dolutegravir (IC50=2.7 nM), a two-metal-binding HIV integrase inhibitor, exhibits medium activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
价 格：￥电议型 号：T6198产 地：美洲
-
T71009Dolutegravir SR Isomer；化合物 Dolutegravir SR IsomerDolutegravir SR Isomer
Dolutegravir SR Isomer is an isomeric derivative of Dolutegravir -- a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.
价 格：￥电议型 号：T71009产 地：中国大陆
-
T70881Dolutegravir RR Isomer；化合物 Dolutegravir RR IsomerDolutegravir RR Isomer
Dolutegravir RR Isomer is an isomer of Dolutegravir -- a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.
价 格：￥电议型 号：T70881产 地：中国大陆
-
T6198Dolutegravir；度鲁特韦S/GSK1349572|||GSK1349572；S/GSK1349572|||GSK1349572|||度鲁特韦|||多替拉韦
Dolutegravir (GSK1349572) (IC50=2.7 nM), a two-metal-binding HIV integrase inhibitor, exhibits medium activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
价 格：￥电议型 号：T6198产 地：中国大陆
-
T36794Dolutegravir O-β-D-Glucuronide；Dolutegravir O-β-D-GlucuronideDolutegravir O-β-D-Glucuronide
Dolutegravir O-β-D-glucuronide is a metabolite of the HIV integrase inhibitor dolutegravir .1It is formed from dolutegravir primarily by the UDP-glucuronosyltransferase (UGT) isoform UGT1A1in vivobut is also metabolized by UGT1A9 in human liver and kidney microsomes and UGT1A3 in human intestinal microsomes.2,1
价 格：￥电议型 号：T36794产 地：中国大陆
-
T36793Dolutegravir M1；Dolutegravir M1Dolutegravir M1
Dolutegravir M1 is a metabolite of the HIV integrase inhibitor dolutegravir .1It is formed primarily by the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1B1.
价 格：￥电议型 号：T36793产 地：中国大陆
-
T2329Dolutegravir sodium；度鲁特韦钠盐GSK1349572|||GSK-1349572A；度鲁特韦钠|||GSK1349572|||度鲁特韦钠盐|||GSK-1349572A
Dolutegravir sodium (GSK-1349572A) salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
价 格：￥电议型 号：T2329产 地：中国大陆
-
T11074Dolutegravir intermediate-1；化合物Dolutegravir intermediate-11-(2,2-dimethoxyethyl)-5-methoxy-6-methoxy
Dolutegravir intermediate-1 (1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid) is a new synthetic Dolutegravir intermediate. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.
价 格：￥电议型 号：T11074产 地：中国大陆
